Lipid lowering

The primary target of lipid lowering therapy is LDL-C lowering .

降脂治疗的首要目标是降低LDL-C。

Elevations in the LDL or bad cholesterol were also seen in some patients , some of whom required the addition of lipid lowering agents .

在一些患者中还可见LDL或“坏胆固醇”增加，其中部分患者需要加用降脂药。

Study of Pantethine on the Blood Lipid Lowering Effect of Rabbits

潘特生降低兔血脂作用的研究

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

稳定型冠心病患者阿托伐他汀强化降脂治疗的作用

Dietary fiber would also benefit people with hypercholesterolemia because of its possible lipid lowering effect .

膳食纤维对血胆脂醇过多的人也有好处，因为它能降低人体内的油脂含量。

Study on compound chitosan blood lipid lowering granule

复方壳聚糖降脂颗粒剂的研究

Lipid lowering effect of pravastatin on glomerulosclerosis protection and treatment

普伐他汀调脂对肾小球硬化防治作用的实验研究

Animals Study on Spirulina as an Adjuvant Blood Lipid Lowering and Immune Function Enhancing Agent

螺旋藻干粉制剂辅助降血脂和调节免疫功能动物实验研究

LDL cholesterol should be the primary target of lipid lowering treatments .

LDL脂蛋白应该作为脂蛋白降低疗法的主要靶标。

In our hospital , the clinical application of lipid lowering drugs were in line with its development trends .

调脂药物的临床应用应符合发展趋势。

Those with relevant diseases and taking lipid lowering drugs were excluded in both groups .

两组中均排除与脂代谢有关的疾病及用药。

Conclusions Lipid lowering therapy in patients with UAP has antiinflammatory effect on vascular endothelium .

结论UAP调脂治疗具有抗血管内皮炎症反应的作用，并独立于降脂之外。

Statins improve endothelial function , reduce oxidative stress , and suppress inflammatory reactions beyond their lipid lowering effect .

他汀类药除降血脂作用外，还有改善血管内皮功能，减少氧化应激，抑制炎性反应等作用。

The researchers say there are parallels to be drawn between homocysteine and lipid lowering .

研究者们说在同型半胱氨酸和脂肪降低之间有相似性可取。

The serum LP ( a ) level was not influenced by lipid lowering drugs , diet and other factors .

Lp（a）水平不受饮食和降脂药物等影响。

Berberine , the major active constituent of Rhizoma coptidis , has a blood lipid lowering function .

小檗碱是中药黄连的主要成分，具有降血脂的功能。

Objective : To learn the application and development trends of lipid lowering drugs in our hospital , and provide a reference for its clinical use .

目的：了解山西博爱医院调脂药物的应用现状与发展趋势，为临床合理用药提供参考。

Conclusion The aggressive lipid lowering treatment with 80 mg of simvastatin is safe and effective to improve the prognosis of AMI patients .

结论辛伐他汀80mg的强化降脂方案安全有效，可以改善急性心肌梗死患者的预后。

Acute coronary syndromes and diabetes : Is intensive lipid lowering beneficial ? Results of the PROVE IT-TIMI 22 trial

强化降脂治疗对于急性冠状动脉综合征伴糖尿病患者是否有益？PROVEIT-TIMI22试验的结果

Conclusion More than half of the hypercholesterolemic patients receiving lipid lowering therapy had not achieved TC and LDL C target levels .

结论超过一半正在接受调脂治疗的患者，其总胆固醇与低密度脂蛋白胆固醇水平并未达到治疗目标。

Atorvastatin is a new generation of HMG-CoA reductase inhibitors ( blood lipid lowering agent of statins class ) .

阿托伐他汀钙是新一代羟甲戊二酰辅酶A（HMG-CoA）还原酶抑制剂（他汀类降血脂药）。

Dietary treatment and success rate of control in hypercholesterolemia patients treated with lipid lowering drugs : a multi-center study of current status on clinical control of hypercholesterolemia in China

药物治疗的高胆固醇血症患者膳食治疗状况与血脂控制达标率&高胆固醇血症临床控制状况多中心协作研究

The two groups were routinely antidiabetic , antihypertensive , lipid lowering and other basic treatment , make blood sugar , blood pressure , lipids get ideal control .

两组均进行常规降糖、降压、调脂等基础治疗，使血糖、血压、血脂达到理想控制状态。

All these suggests that GXTF has effects of anti platelet aggregation , anti thrombus formation , lipid lowering and antioxidation .

由此表明GXTF具有抗血小板聚集和血栓形成，降血脂和抗氧化作用。

This correlation is not complete because medhya rasayan or fat metabolism implies more than mere lipid lowering activity .

但是，这种关联并不完整，因为“medhyarasayan”（或者说脂肪新陈代谢）不仅仅指胆固醇降低活性。

Lipid Lowering Activity of Total Flavonoids from Mulberry Leaves in Two Hyperlipidemic Animal Models The comparison study of pioglitazone and rosiglitazone on type 2 diabetes with hyperlipemia

桑叶总黄酮对高脂血症动物的降血脂效应吡格列酮和罗格列酮治疗2型糖尿病高脂血症的临床比较研究

Study on weight losing and lipid lowering on the model of obesity rats by luteolin Optimal NPK Fertilization and Its Effect on Naked Barley Yield in Sub-highland Region

木樨草素对肥胖模型大鼠减肥降脂作用的研究

Objective : To evaluate the prognostic value of intensive lipid lowering treatment in old patients with unstable angina pectoris ( UAP ) and study the mechanism of lipid lowering drugs .

目的：评价强化降脂治疗对老年不稳定性心绞痛（UAP）病人预后的影响，探讨降脂药物的作用机制。

Objective : To observe the plasma levels of C-reactive protein ( CRP ) and fibrinogen ( FIB ) in patients with hyperlipidemia before and after the lipid lowering therapy .

目的：观察高脂血症患者调脂治疗前后，血浆C-反应蛋白（CRP）及维蛋白原（FIB）的水平变化。

Methods : Effect of AAM was observed in puromycin amino-nucleoside induced nephrotic syndrome model of rat , and pravachol , an effective lipid lowering medicine , was used as Positive control .

方法：采用嘌呤霉素引起的肾病综合征大鼠模型，以有效的降脂药普伐他汀作阳性对照，观察黄芪当归合剂的作用。